Tharimmune (THAR, Financial) has received pivotal feedback from the U.S. Food and Drug Administration regarding its product, TH104. The FDA has indicated that no additional clinical trials are required before the submission of a 505(b)(2) New Drug Application for TH104. This formulation is a buccal film of nalmefene, engineered for quick absorption and designed to bypass liver metabolism. It is intended for the temporary prevention of respiratory and nervous system depression in military personnel and chemical incident responders potentially exposed to potent opioids such as weaponized fentanyl.
This regulatory progress highlights the significant demand for medical countermeasures in light of the growing threat of synthetic opioid weaponization. A recent assessment of the U.S. Strategic National Stockpile underscored the need for effective prophylactic solutions against chemical threats, particularly high-potency opioids. The assessment pointed to a critical requirement for countermeasures that can be deployed swiftly to combat exposure risks.
The Department of Defense has already taken steps in this direction by acquiring a naloxone auto-injector for similar prophylactic purposes. Tharimmune’s TH104 offers a potentially longer duration of action and operational advantages, especially when responders are equipped with full protective gear, making it a promising candidate for addressing these national security threats.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Tharimmune Inc (THAR, Financial) is $5.00 with a high estimate of $5.00 and a low estimate of $5.00. The average target implies an upside of 316.70% from the current price of $1.20. More detailed estimate data can be found on the Tharimmune Inc (THAR) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Tharimmune Inc's (THAR, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
